A one-year follow-up study conducted by researchers at Banaras Hindu University (BHU) has found that nearly one-third of individuals who received Bharat Biotech's Covaxin reported 'adverse events ...
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported ‘adverse events of special interest,’ or AESI, according to a one-year follow up study ...
New Delhi: Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up ...
1 in 3 Covaxin takers have reported adverse events as per a new study by BHU. What are these side effects and should people who got jabbed need to worry? A team of researchers at BHU in a one-year ...
NEW DELHI: Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up ...
Covaxin, the Covid-19 vaccine developed by Bharat Biotech, has caused several adverse side effects in recipients, including respiratory tract infections and menstrual abnormalities, a new study ...
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual ...
A study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI). Among 926 participants, viral ...
Nearly 50 per cent of the participants complained of infections during the follow-up period, predominated by viral upper respiratory tract infections. A one-year follow-up study conducted by ...
Nearly one-third of the individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study conducted ...
Nearly one-third of 926 individuals who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI, according to a one-year follow up study ...